Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/377
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Obeyesekere, Manoj | - |
dc.contributor.other | Sy, Raymond | - |
dc.contributor.other | Modi, Simon | - |
dc.date.accessioned | 2015-09-16T07:03:44Z | - |
dc.date.available | 2015-09-16T07:03:44Z | - |
dc.date.issued | 2012-12 | - |
dc.identifier.citation | Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1451-3 | en_US |
dc.identifier.issn | 1477-9072 | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/377 | - |
dc.description | Editorial | en_US |
dc.description.abstract | Successful catheter ablation of the accessory pathways eliminates the small risk of sudden death associated with the Wolff-Parkinson-White (WPW) ECG in asymptomatic patients. The low rate of serious complications and even death associated with catheter ablation arguable offsets the benefit associated with uniform catheter ablation in this population. The low positive predictive value of non-invasive and invasive variables along with the cost also argue against a uniform invasive approach in asymptomatic patients. Nonetheless, an invasive strategy in certain clinical circumstances and in patients who remain concerned of the small risk of life-threatening arrhythmia as a first presentation after a thoughtful discussion of the risks and benefits of an invasive approach is reasonable. | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.subject | Victorian Heart Centre, Epworth Hospital, Melbourne, Australia | en_US |
dc.subject | Asymptomatic | en_US |
dc.subject | Atrial Fibrilation | en_US |
dc.subject | Catheter Ablation | en_US |
dc.subject | Electrophysiology | en_US |
dc.subject | Risk | en_US |
dc.subject | Sudden Death | en_US |
dc.subject | Supraventricular Tachycardia | en_US |
dc.subject | Ventricular Fibrilation | en_US |
dc.subject | Wolff-Parkinson-White | en_US |
dc.subject | Young Patients | en_US |
dc.subject | Electrocardiography | en_US |
dc.subject | WPW | en_US |
dc.title | When can ablation be considered a reasonable option in young asymptomatic patients with a Wolff-Parkinson-White ECG? | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1586/erc.12.146 | en_US |
dc.identifier.journaltitle | Expert Review of Cardiovascular Therapy | en_US |
dc.description.pubmeduri | http://www.ncbi.nlm.nih.gov/pubmed/23253267 | en_US |
dc.description.affiliates | University of Sydney | en_US |
dc.description.affiliates | Liverpool Heart and Chest Hospital | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cardiac Sciences |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.